These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10918510)

  • 21. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in understanding adjuvant immunotoxicity mechanisms.
    Batista-Duharte A; Lindblad EB; Oviedo-Orta E
    Toxicol Lett; 2011 Jun; 203(2):97-105. PubMed ID: 21392560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report on carcinogens.
    Rep Carcinog; 2004; 11():I1-6. PubMed ID: 21089791
    [No Abstract]   [Full Text] [Related]  

  • 25. TLR4 agonists as vaccine adjuvants: a chemist's perspective.
    Johnson DA
    Expert Rev Vaccines; 2013 Jul; 12(7):711-3. PubMed ID: 23885814
    [No Abstract]   [Full Text] [Related]  

  • 26. Update of carcinogenicity studies in animals and humans of 535 marketed pharmaceuticals.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutat Res; 2012; 750(1):1-51. PubMed ID: 21968027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of thresholds for carcinogenicity on linear and logarithmic dose scales.
    Andersen M; Renwick A
    Hum Exp Toxicol; 2005 Nov; 24(11):603-5; author reply 605-7. PubMed ID: 16323578
    [No Abstract]   [Full Text] [Related]  

  • 29. Lifetime mouse cancer tests--the end of an era?
    Alden CL
    Toxicol Pathol; 1998; 26(4):584. PubMed ID: 9715520
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of rodent carcinogenesis bioassays.
    Ward JM
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):212. PubMed ID: 18029286
    [No Abstract]   [Full Text] [Related]  

  • 31. Highlights of International meeting on Alternative Methods of Carcinogenicity Testing, Leesburg, VA, November 1-3, 2000, Sponsored by the Health and Environmental Sciences Institute.
    Jollow DJ
    J Agromedicine; 2004; 9(2):427-9. PubMed ID: 19785235
    [No Abstract]   [Full Text] [Related]  

  • 32. IARC ranking of carcinogenicity evidence: how is the message delivered and perceived?
    Lotti M
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):236-41. PubMed ID: 8041921
    [No Abstract]   [Full Text] [Related]  

  • 33. Predicting chemicals causing cancer in animals as human carcinogens.
    Huff J
    Occup Environ Med; 2010 Oct; 67(10):720. PubMed ID: 20837652
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New metabolizable immunologic adjuvant for human use. IX. Large-scale trials with multiple lots in different regimens.
    Stokes J; Weibel RE; Woodhour AF; McAleer WJ; Potkonski LA; Hilleman MR
    JAMA; 1969 Mar; 207(11):2067-72. PubMed ID: 4885972
    [No Abstract]   [Full Text] [Related]  

  • 36. Genotoxicity and carcinogenicity of metronidazole.
    Dobiás L; Cerná M; Rössner P; Srám R
    Mutat Res; 1994 Jun; 317(3):177-94. PubMed ID: 7515153
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
    Parry JM
    IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
    [No Abstract]   [Full Text] [Related]  

  • 38. Interspecies sensitivity to chemical carcinogens.
    Nesnow S; Agarwal SC; Lambert GR; Earley K; Gupta RC
    Prog Clin Biol Res; 1992; 374():381-97. PubMed ID: 1620714
    [No Abstract]   [Full Text] [Related]  

  • 39. AnergiX.RA Corixa.
    Prokaeva T
    Curr Opin Investig Drugs; 2000 Sep; 1(1):70-4. PubMed ID: 11249598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of pharmacological properties of betulin bishemiphthalate].
    Karachurina LT; Sapozhnikova TA; Zarudiĭ FS; Flekhter OB; Nigmatullina LR; Galin FZ
    Eksp Klin Farmakol; 2003; 66(4):56-9. PubMed ID: 14558356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.